Tbx1 hypomorphic allele (Tbx1 neo/þ ) [2] for attempting to recapitulate the human genotype and phenotype correlation. Mice homozygous for this hypomorphic allele expressed around 25 % of Tbx1 mRNA compared to wild-type mice. We demonstrated that Tbx1 is a dosage-dependent gene and believe that the Tbx1 dosage can be affected by genetic and/or environmental modifiers because of highly variable phenotype of 22q11DS instead of the relatively uniform chromosomal microdeletion. We are trying to create the phenotype variability of PTA in this hypomorphic model ( Fig. 28.1 ) by application of environmental modifiers. Through this study, we would better understand the interaction between the gene dosage and environmental factors during the development of outflow tract defects.
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